NCT02427841 - Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 21, 2016

Primary Completion Date

November 12, 2019

Study Completion Date

December 12, 2022

Conditions

Pancreatic AdenocarcinomaResectable Pancreatic Carcinoma

Interventions

DRUG

Fluorouracil

Given IV

DRUG

Gemcitabine

Given IV

RADIATION

Image Guided Radiation Therapy

Undergo IG-IMRT

RADIATION

Intensity-Modulated Radiation Therapy

Undergo IG-IMRT

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Nab-paclitaxel

Given IV

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

Trial Locations (1)

OHSU Knight Cancer Institute, Portland